CALABRESI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 1.035
EU - Europa 863
AS - Asia 536
SA - Sud America 74
AF - Africa 10
OC - Oceania 7
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.527
Nazione #
US - Stati Uniti d'America 1.025
RU - Federazione Russa 279
PL - Polonia 224
SG - Singapore 180
CN - Cina 133
IT - Italia 122
HK - Hong Kong 89
BR - Brasile 56
KR - Corea 51
IE - Irlanda 48
DE - Germania 42
SE - Svezia 35
CH - Svizzera 30
VN - Vietnam 29
FR - Francia 26
FI - Finlandia 20
GB - Regno Unito 18
IN - India 15
JO - Giordania 11
AR - Argentina 9
ID - Indonesia 8
AU - Australia 7
CA - Canada 7
JP - Giappone 7
NL - Olanda 6
ES - Italia 5
BE - Belgio 4
EC - Ecuador 4
BD - Bangladesh 3
UZ - Uzbekistan 3
ZA - Sudafrica 3
CI - Costa d'Avorio 2
CL - Cile 2
MX - Messico 2
TN - Tunisia 2
TR - Turchia 2
UA - Ucraina 2
AL - Albania 1
AQ - Antartide 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
EG - Egitto 1
IL - Israele 1
IQ - Iraq 1
KE - Kenya 1
KW - Kuwait 1
MU - Mauritius 1
PK - Pakistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.527
Città #
Santa Clara 263
Warsaw 223
Ashburn 112
Singapore 110
Hong Kong 81
Fairfield 73
Chandler 52
Seoul 50
Dublin 48
Florence 41
San Jose 41
Woodbridge 37
Seattle 36
Houston 33
Hefei 32
Beijing 31
Ann Arbor 30
Cambridge 30
Bern 28
Munich 24
Wilmington 24
Buffalo 17
Los Angeles 16
Moscow 15
Paris 15
Altamura 14
Dallas 14
Lawrence 14
The Dalles 13
Princeton 11
Turku 11
Bremen 10
Kent 9
New York 9
Boston 8
Ho Chi Minh City 8
Hanoi 7
Mumbai 7
Clifton 6
Dong Ket 6
Jakarta 6
Melbourne 6
Shanghai 6
Tokyo 6
Bengaluru 5
Dearborn 5
Milan 5
São Paulo 5
Brussels 4
Cagliari 4
Castel Maggiore 4
Frankfurt am Main 4
Helsinki 4
London 4
San Diego 4
Tianjin 4
Boardman 3
Brooklyn 3
Hangzhou 3
Hillsboro 3
Montreal 3
Redwood City 3
Shenzhen 3
Tashkent 3
Yubileyny 3
Abidjan 2
Ankara 2
Basel 2
Birigui 2
Cantagallo 2
Cusano Milanino 2
Ealing 2
Edmonton 2
Falls Church 2
Fiesole 2
Guayaquil 2
Krasnodar 2
Kunming 2
Lappeenranta 2
Medford 2
Phoenix 2
Pretoria 2
Puerto Madryn 2
Redondo Beach 2
Reston 2
Romainville 2
Salvador 2
Seville 2
Topeka 2
Alagoinhas 1
Andover 1
Aswān 1
Atlanta 1
Augusta 1
Austin 1
Barra do Piraí 1
Bauru 1
Belford Roxo 1
Belo Horizonte 1
Benito Juárez 1
Totale 1.771
Nome #
Validation of the differential prognostic impact of type 1/type 1-like versus type 2/type 2-like CALR mutations in myelofibrosis 310
Inhibitors of the PI3K/mTOR pathway prevent STAT5 phosphorylation in JAK2V617F mutated cells through PP2A/ CIP2A axis 236
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 230
Characterization of novel molecular targets and mechanisms in Philadelphia-negative Myeloproliferative Neoplasms 206
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: Pathogenetic insight and diagnostic value 196
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 178
Calreticulin mutation-specific immunostaining in myeloproliferative neoplasms: pathogenetic insight and diagnostic value. 172
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature 159
Molecular Characterization of Response/Loss-of-Response to Ruxolitinib in Patients with Myelofibrosis 152
The MPL mutation 148
Activated IL-6 signaling contributes to the pathogenesis of, and is a novel therapeutic target for, CALR-mutated MPNs 138
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 136
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms 99
Immunoblotting-assisted assessment of JAK/STAT and PI3K/Akt/mTOR signaling in myeloproliferative neoplasms CD34+ stem cells 73
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 71
CD20+ T Cells in Multiple Sclerosis: From Pathogenesis to Treatment-Induced Depletion 48
Totale 2.552
Categoria #
all - tutte 7.426
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.426


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 0 8 10 15 23 7 10
2021/202270 1 2 8 0 2 4 0 7 5 6 14 21
2022/2023268 15 51 14 22 15 34 30 14 29 2 9 33
2023/2024132 2 15 15 5 12 16 1 37 4 5 13 7
2024/2025859 27 72 44 131 212 128 18 41 54 38 42 52
2025/2026620 112 109 101 79 117 42 60 0 0 0 0 0
Totale 2.552